Published in Circulation on December 06, 2004
Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med (2008) 5.13
Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 5.05
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm (2013) 2.22
Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol (2013) 2.16
Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression. J Am Coll Cardiol (2009) 1.65
A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. J Am Coll Cardiol (2012) 1.59
Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit? Neth Heart J (2013) 1.35
Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail (2009) 1.24
Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol (2009) 1.18
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes (2015) 1.18
Clinical trials of antiarrhythmic therapies and optimizing health care resource deployment: the need for a paradigm shift. J Interv Card Electrophysiol (2012) 1.04
Mortality following defibrillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol (2006) 1.03
The subcutaneous ICD-current evidence and challenges. Cardiovasc Diagn Ther (2014) 0.97
Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing). JACC Heart Fail (2013) 0.91
Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease. J Cardiovasc Magn Reson (2013) 0.90
Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial. Eur Heart J (2013) 0.90
Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol (2012) 0.89
Ventricular scars and ventricular tachycardia. Trans Am Clin Climatol Assoc (2009) 0.89
Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD) A systematic review. BMC Cardiovasc Disord (2009) 0.86
Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention. PLoS One (2013) 0.85
The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace (2010) 0.83
Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials. Heart Rhythm (2016) 0.82
The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population. J Geriatr Cardiol (2011) 0.82
Phone-delivered mindfulness training for patients with implantable cardioverter defibrillators: results of a pilot randomized controlled trial. Ann Behav Med (2013) 0.81
The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy. Curr Cardiol Rep (2013) 0.80
Predictors and clinical impact of inappropriate implantable cardioverter-defibrillator shocks in Korean patients. J Korean Med Sci (2012) 0.80
Cognitive and behavioral treatments for anxiety and depression in a patient with an implantable cardioverter defibrillator (ICD): a case report and clinical discussion. J Clin Psychol Med Settings (2009) 0.80
Catheter ablation of ventricular tachycardia in patients with post-infarction cardiomyopathy. Korean Circ J (2014) 0.79
Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy. Circ Arrhythm Electrophysiol (2012) 0.79
Increased Platelet-to-Lymphocyte Ratios and Low Relative Lymphocyte Counts Predict Appropriate Shocks in Heart Failure Patients with ICDs. Acta Cardiol Sin (2016) 0.78
Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy. Heart Fail Rev (2011) 0.78
Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol (2015) 0.78
Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. J Interv Card Electrophysiol (2012) 0.78
The spatial QRS-T angle: implications in clinical practice. Curr Cardiol Rev (2013) 0.78
Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality. Circ Cardiovasc Imaging (2017) 0.77
Will innervation imaging predict ventricular arrhythmias in ischaemic cardiomyopathy? Eur J Nucl Med Mol Imaging (2006) 0.77
Electrocardiographic Markers and the Left Ventricular Ejection Fraction have Cumulative Effects on Risk of Sudden Cardiac Death. JACC Clin Electrophysiol (2015) 0.77
Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials. J Interv Card Electrophysiol (2015) 0.77
[Is intraoperative ICD-testing still necessary?]. Herzschrittmacherther Elektrophysiol (2010) 0.76
Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator. J Interv Card Electrophysiol (2011) 0.76
Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology. J Nucl Cardiol (2011) 0.76
Catheter ablation of ventricular tachycardia. From indication to three-dimensional mapping technology. Herz (2009) 0.76
Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. Eur Heart J (2011) 0.76
Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study design. J Arrhythm (2014) 0.76
Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data. BMC Health Serv Res (2013) 0.76
Prophylactic ICDs: can (and will) the medical marketplace decide their role? J Interv Card Electrophysiol (2005) 0.75
Prognostic Significance of Frontal QRS-T Angle in Patients with Idiopathic Dilated Cardiomyopathy. Chin Med J (Engl) (2016) 0.75
Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry. BMC Cardiovasc Disord (2012) 0.75
Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging. Int J Cardiovasc Imaging (2012) 0.75
Compatibility of electroanatomical mapping systems with a concurrent percutaneous axial flow ventricular assist device. J Cardiovasc Electrophysiol (2014) 0.75
Arrhythmias: Catheter ablation for prevention of ventricular tachycardia. Nat Rev Cardiol (2010) 0.75
The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. Arrhythm Electrophysiol Rev (2016) 0.75
Cardiac sympathetic activity in chronic heart failure: cardiac (123)I-mIBG scintigraphy to improve patient selection for ICD implantation. Neth Heart J (2016) 0.75
Principles and techniques of imaging in identifying the substrate of ventricular arrhythmia. J Nucl Cardiol (2015) 0.75
Impact of denervated myocardium on improving risk stratification for sudden cardiac death. Trans Am Clin Climatol Assoc (2014) 0.75
Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram. J Cardiovasc Electrophysiol (2010) 0.75
An implantable defibrillator and what else? Eur Heart J (2009) 0.75
Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance. J Nucl Cardiol (2016) 0.75
Long-Term Prognosis of Patients with an Implantable Cardioverter-Defibrillator in Korea. Yonsei Med J (2017) 0.75
Radio frequency ablation for VT--a cost-effective tool to combat SCD in developing countries. Indian Heart J (2013) 0.75
Factors influencing utilization of the primary prevention implantable defibrillator. PLoS One (2015) 0.75
A Questionable Indication For ICD Extraction After Successful VT Ablation. J Atr Fibrillation (2015) 0.75
Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death. Europace (2016) 0.75
Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Circ Arrhythm Electrophysiol (2016) 0.75
Sudden Cardiac Death: A Review Focused on Cardiovascular Imaging. J Cardiovasc Echogr (2017) 0.75
Results of recent studies in catheter ablation of ventricular tachycardias: in whom to abandon the ICD? Herz (2009) 0.75
Fighting against sudden death: a single or multidisciplinary approach. J Interv Card Electrophysiol (2007) 0.75
Epicardial ablation as a bailout in electrical storm? Herzschrittmacherther Elektrophysiol (2014) 0.75
[Catheter ablation of ventricular extrasystoles and ventricular tachycardia in the elderly]. Herzschrittmacherther Elektrophysiol (2017) 0.75
Ventricular tachycardia inducibility after radiofrequency ablation affects the outcomes in patients with coronary artery disease and implantable cardioverter-defibrillators: The role of left ventricular function. J Interv Card Electrophysiol (2009) 0.75
[ICD therapy for the primary prevention of sudden cardiac arrest. The patient after a myocardial infarction]. Herzschrittmacherther Elektrophysiol (2010) 0.75
Clinical utility of cardiac innervation imaging in patients with heart failure. J Nucl Cardiol (2017) 0.75
Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure. Heart Fail Rev (2016) 0.75
Socio-economic analysis of cardiac resynchronization therapy. J Interv Card Electrophysiol (2007) 0.75
How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection? Heart Fail Rev (2012) 0.75
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med (2009) 12.44
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol (2008) 4.63
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13
Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med (2014) 3.80
Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation (2004) 3.78
Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol (2008) 3.73
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA (2007) 3.32
Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol (2003) 3.05
Long QT syndrome in adults. J Am Coll Cardiol (2007) 2.93
Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation (2007) 2.88
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol (2011) 2.84
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm (2009) 2.82
Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). J Am Coll Cardiol (2013) 2.68
Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol (2009) 2.65
Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol (2004) 2.63
Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation (2004) 2.63
Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol (2005) 2.62
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.56
Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation (2006) 2.52
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation (2010) 2.49
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2010) 2.41
The influence of public reporting of outcome data on medical decision making by physicians. Arch Intern Med (2005) 2.40
Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation (2008) 2.40
Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol (2008) 2.39
Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol (2006) 2.32
Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol (2012) 2.31
Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation (2011) 2.26
Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol (2012) 2.26
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol (2003) 2.22
Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation (2002) 2.20
Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol (2002) 2.19
ECGScan: a method for conversion of paper electrocardiographic printouts to digital electrocardiographic files. J Electrocardiol (2005) 2.17
Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol (2011) 2.15
Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol (2008) 2.13
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA (2006) 2.12